Most Popular
1. Banking Crisis is Stocks Bull Market Buying Opportunity - Nadeem_Walayat
2.The Crypto Signal for the Precious Metals Market - P_Radomski_CFA
3. One Possible Outcome to a New World Order - Raymond_Matison
4.Nvidia Blow Off Top - Flying High like the Phoenix too Close to the Sun - Nadeem_Walayat
5. Apple AAPL Stock Trend and Earnings Analysis - Nadeem_Walayat
6.AI, Stocks, and Gold Stocks – Connected After All - P_Radomski_CFA
7.Stock Market CHEAT SHEET - - Nadeem_Walayat
8.US Debt Ceiling Crisis Smoke and Mirrors Circus - Nadeem_Walayat
9.Silver Price May Explode - Avi_Gilburt
10.More US Banks Could Collapse -- A Lot More- EWI
Last 7 days
Stock Market Volatility (VIX) - 25th Mar 24
Stock Market Investor Sentiment - 25th Mar 24
The Federal Reserve Didn't Do Anything But It Had Plenty to Say - 25th Mar 24
Stock Market Breadth - 24th Mar 24
Stock Market Margin Debt Indicator - 24th Mar 24
It’s Easy to Scream Stocks Bubble! - 24th Mar 24
Stocks: What to Make of All This Insider Selling- 24th Mar 24
Money Supply Continues To Fall, Economy Worsens – Investors Don’t Care - 24th Mar 24
Get an Edge in the Crypto Market with Order Flow - 24th Mar 24
US Presidential Election Cycle and Recessions - 18th Mar 24
US Recession Already Happened in 2022! - 18th Mar 24
AI can now remember everything you say - 18th Mar 24
Bitcoin Crypto Mania 2024 - MicroStrategy MSTR Blow off Top! - 14th Mar 24
Bitcoin Gravy Train Trend Forecast 2024 - 11th Mar 24
Gold and the Long-Term Inflation Cycle - 11th Mar 24
Fed’s Next Intertest Rate Move might not align with popular consensus - 11th Mar 24
Two Reasons The Fed Manipulates Interest Rates - 11th Mar 24
US Dollar Trend 2024 - 9th Mar 2024
The Bond Trade and Interest Rates - 9th Mar 2024
Investors Don’t Believe the Gold Rally, Still Prefer General Stocks - 9th Mar 2024
Paper Gold Vs. Real Gold: It's Important to Know the Difference - 9th Mar 2024
Stocks: What This "Record Extreme" Indicator May Be Signaling - 9th Mar 2024
My 3 Favorite Trade Setups - Elliott Wave Course - 9th Mar 2024
Bitcoin Crypto Bubble Mania! - 4th Mar 2024
US Interest Rates - When WIll the Fed Pivot - 1st Mar 2024
S&P Stock Market Real Earnings Yield - 29th Feb 2024
US Unemployment is a Fake Statistic - 29th Feb 2024
U.S. financial market’s “Weimar phase” impact to your fiat and digital assets - 29th Feb 2024
What a Breakdown in Silver Mining Stocks! What an Opportunity! - 29th Feb 2024
Why AI will Soon become SA - Synthetic Intelligence - The Machine Learning Megatrend - 29th Feb 2024
Keep Calm and Carry on Buying Quantum AI Tech Stocks - 19th Feb 24

Market Oracle FREE Newsletter

How to Protect your Wealth by Investing in AI Tech Stocks

How to Double Your Money by Investing in Biotech

Companies / BioTech Jun 21, 2013 - 01:42 PM GMT

By: Money_Morning

Companies

Diane Alter writes: Some of the most lucrative opportunities you can find now are in the biotechnology industry – which is why we've been working to uncover the best ways for how to invest in this sector.

The best biotech companies overflow with innovation. They can offer a steady stream of game-changing products – which often translates to record-breaking revenue.


The biotech industry is also known for its stiff competition. The race to be a consumer favorite causes companies to take big risks.

Sometimes, these lead to embarrassing flops, but when they get it right, the payoffs are huge.

That's a big reason why funding, often difficult to secure, is getting easier.

Greg Simon, CEO of Poliwogg, a firm that hunts for investable innovative drug makers, says "crowd funding" by private ventures, legalized by Congress last year, is spreading the risk among cautious yet interested investors.

"There is not a riskier business than health," Simon said at the Milken Institutes Global Conference in Los Angeles in late April. "This is going to democratize the flow of capital into companies."

Other experts in the field remain bullish –even as the industry has already logged huge gains.

Indeed, biotech stocks are up about 62% over the last two years. Propelled by new drug debuts, research advances and a full pipeline, a long stretch of rewarding breakthrough products should continue to flow in the years ahead.

Rajiv Kaul, manager of the $5.3 billion Fidelity Select Biotechnology Fund said at the Los Angeles event, "Despite the challenges, this is the best time for biotech ever."

Jodi Black, program director at the National Institutes of Health shared that sentiment, "The scientific potential has never been greater. Now is not the time to retrench."

The sector has enjoyed vigorous merger and acquisition activity over the last couple years, a trend that's expected to continue. Also expected is a significant pick-up in licensing activities and collaborations.

Higher demand for medicines, government initiatives for healthcare, new patient population and increasing use of generics will also drive the industry.

Another reason why now's the time to know how to invest in biotech: We are heading into what Kaul calls a golden age for the industry.

According to the IMS Institute, the branded medicine market is expected to rise from $596 billion in 2011 to some $645 billion by 2016. The introduction of medicines and procedures targeting unmet needs and soaring patient access from Obamacare will also boost industry growth.

"Investors who take a long-term view get rewarded because great things could still be ahead of us," Kaul shared in a recent Barron's interview.

However, the recent surge has created a conundrum for investors thanks to skyrocketing stock prices and high multiples in the diverse sector.

Moreover, there is the high rate of failure. The majority of experimental drugs in clinic stages never make it to market. Plus, drugs already approved face pricing pressure and must remain innovative.

So, investors need to tread carefully.

How to Invest in Biotech Now

Money Morning's Tech Specialist Michael A. Robinson has found the Holy Grail in this profitable and promising industry.

"It has actual double your money potential. In fact, you'll be stunned at just how quickly every $1 you invest will turn into $2 in holdings," Robinson explained.

The ETF is the iShares NASDAQ Biotechnology Index (Nasdaq: IBB).

Roughly 58% of its funds are invested in biotech behemoths like Gilead Sciences Inc. (Nasdaq; GILD), Regeneron Pharmaceuticals Inc (Nasdaq: REGN), Amgen Inc. (Nasdaq: AMGN), Celgene Corp. (Nasdaq: CELG) and Alexion Pharmaceuticals Inc. (Nasdaq: ALXN).

It also invests in a number of "stealth small caps."

Some 70-80 new companies are created every year with opportunistic new treatments. This steady channel of invention underscores a cache of investment opportunity for the future.

"The IBB is exactly the type of strategic play every tech investor should make. It's both the easiest and lowest-risk way I know of to put a broad swath of market leaders and perennial winners in your hands ... immediately," Robinson says.

Read Robinson's full report on why IBB is how to invest in biotech: A Tech Investing Homerun.

Source :http://moneymorning.com/2013/06/19/how-to-invest-in-biotech-now-and-double-your-money/

Money Morning/The Money Map Report

©2013 Monument Street Publishing. All Rights Reserved. Protected by copyright laws of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), of content from this website, in whole or in part, is strictly prohibited without the express written permission of Monument Street Publishing. 105 West Monument Street, Baltimore MD 21201, Email: customerservice@moneymorning.com

Disclaimer: Nothing published by Money Morning should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized investent advice. We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication, or after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended by Money Morning should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company.

Money Morning Archive

© 2005-2022 http://www.MarketOracle.co.uk - The Market Oracle is a FREE Daily Financial Markets Analysis & Forecasting online publication.


Post Comment

Only logged in users are allowed to post comments. Register/ Log in